Cargando…
Development of HIF-1 inhibitors for cancer therapy
Intratumour hypoxia has long been considered a driving force of tumour progression and a negative prognostic factor in human cancers. The discovery of hypoxia inducible factors (HIFs), which mediate transcriptional responses to changes in oxygen levels, has renewed enthusiasm for the discovery and d...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832082/ https://www.ncbi.nlm.nih.gov/pubmed/19674190 http://dx.doi.org/10.1111/j.1582-4934.2009.00876.x |